June 23 (Reuters) - CanSino Biologics Inc :
* NEW DRUG APPLICATION APPROVAL FOR MCV2 GRANTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA
* GROUP A AND GROUP C MENINGOCOCCAL CONJUGATE VACCINE GRANTED NEW DRUG APPLICATION APPROVAL BY CHINA'S NMPA
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论